MDS Virtual Congress 2020 » Epidemiology

Meeting: MDS Virtual Congress 2020

Age at onset and Parkinson’s disease progression

G. D'Urso, K. Taylor, T. Kustermann, N. Pavese, G. Pagano (Basel, Switzerland)

An Apparent Cluster of Parkinson’s Disease (PD) in a Golf Community

J. Nutt, A. Zajack, J. Sandsness, V. Palmer, C. Meng, C. Tanner, P. Spencer (Portland, OR, USA)

Application of a Simple Parkinson’s Disease Risk Score in a Longitudinal Population Based Cohort

K. Marini, P. Mahlknecht, F. Tutzer, H. Stockner, A. Gasperi, A. Djamshidian-Tehrani, P. Willeit, S. Kiechl, J. Willeit, G. Rungger, A.J Noyce, A. Schrag, W. Poewe, K. Seppi (Innsbruck, Austria)

Association Between Diet & Parkinson’s Disease Progression

L. Mischley, J. Farahnik (Kenmore, WA, USA)

Association between prediagnostic symptoms and patterns of treatment initiation in people with Parkinson´s disease in the United Kingdom

L. Rutten-Jacobs, S. Roumpanis, Y. Liu, P. Coloma (Basel, Switzerland)

Association of environmental exposure to herbicides, fungicides, and insecticides used in agriculture with incidence of Parkinson’s disease in the French general population

L. Perrin, J. Spinosi, L. Chaperon, D. Jezewski-Serra, M. El Yamani, F. Moisan, A. Elbaz (Villejuif, France)

Carers of People Living with Parkinson’s Disease, the 2019 European Realities

H. Rossinot, P.M Martin, P. Odin, K.R Chaudhuri, C. Billoet, S. Lindwall (Nancy, France)

Characteristics of prescribers for Parkinson’s disease patients: A nationwide study on 2017 Medicare data

S. Miri, D. Enayati, Y. Torres-Yaghi, A. Carwin, S. Nakano, M.W Anjum, F.S Amjad, F. Pagan (Washington, DC, USA)

Demographic characteristics of in-hospital deaths among patients with Parkinson’s disease

O. Phillips, Z. Kunicki, U. Ackbar, R. Jones, A. D’Abreu, J. Friedman (Providence, RI, USA)

Diagnostic Demography of the Ataxia Unit at UNIFESP: 12 years experience

B. Massuyama, M. Gama, F. Abrantes, F. Filho, F. Maggi, R. Salomao, J. Freitas, S. Costa, I. Raslan, G. Diaferia, P. Matos, V. Ciarlariello, C. Jaques, M. Moraes, J. Pedroso, O. Barsottini (Sao Paulo, Brazil)

Disparities in access to care and research participation among individuals with advanced Parkinson’s Disease: Comparison of participants in a home visit model vs. national registry

J. Fleisher, E. Klostermann, E. Myrick, D. Mitchem, J. Lee, K. Woo, B. Ouyang, N. Witek, J. Beck, D. Hall, J. Chodosh (Chicago, IL, USA)

Emerging motor dysfunction in those at-risk of Parkinson’s disease: 5-year follow-up of PREDICT-PD participants

C. Simonet, A. Schrag, J. Bestwick, A. Lees, A. Noyce (London, United Kingdom)

Estimation of latent class mixed models towards discovery of subgroup trajectories of MDS-UPDRS part II, part III, and ambulatory capacity in Parkinson’s disease

C. Venuto, R. Zielinski, G. Smith, M. Javidnia, K. Kieburtz (Rochester, NY, USA)

Estimation of the 2020 Global Population of Parkinson’s Disease (PD)

N. Maserejian, L. Vinikoor-Imler, A. Dilley (Cambridge, MA, USA)

Improving estimation of Parkinson’s disease risk – enhancing the PREDICT-PD algorithm

J. Bestwick, S. Auger, D. Grosset, S. Kanavou, G. Giovannoni, A. Lees, J. Cuzick, C. Simonet, R. Rees, D. Rack, M. Jitlal, A. Schrag, A. Noyce (London, United Kingdom)

Incidence and survival of psychosis in patients with Parkinson’s Disease (1991-2010)

M. Hajeb, C. Stang, E. Camerucci, T. Turcano, A. Mullan, P. Martin, V. Abler, M. Splett, N. Rashid, J. Bower, M. Mielke, R. Savica (Rochester, MN, USA)

Incidence of Hip Fracture in People with Parkinson’s Disease at the Tertiary Care Hospital

M. Ruhullah, K. Shambhaw (Birganj, Nepal)

Initial Results from the Zambian Epidemiology of Parkinson’s disease and Healthcare Registry (ZEPHyR)

T. Lee, O. Siddiqi, M. Atadzhanov, D. Saylor, J. Fleisher (Aurora, CO, USA)

Measuring Unmet Need in Underserved Parkinson’s Populations (UPPs)

S. Rosenfeld, M. Feeney, V. Todaro, A. Willis (New York, NY, USA)

Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank

D. Belete, B. Jacobs, J. Bestwick, C. Blauwendraat, S. Bandres-Ciga, K. Heilbron, R. Dobson, M. Nalls, A. Singleton, J. Hardy, G. Giovannoni, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

Parkinson’s Disease in Israel – Initial Symptoms and Comorbidities from 20 years of Follow Up in a Population-based Cohort

Y. Barer, N. Gavrielov, P. Coloma, M. Martinec, I. Korolev, I. Goldshtein (Tel Aviv, Israel)

Parkinson’s Disease in the Middle East, North Africa and South Asia: A Scoping Review

H. Khalil, J. Siddiqui, L. Chahine, Z. Aldaajani, M. Abu Al-Melh, F. Abdullah, H. Amer, M. Ben Djebara, M. Salari, S. Khan, W. Regragui, M. Abu Snineh, S. Mittat, J. Bajwa (Irbid, Jordan)

Pesticide Exposure in PD with and without Genetic Risk Variants

E. Brown, C. Meng, S. Goldman, C. Tanner (San Francisco, CA, USA)

Predicting the effects of Tumor Necrosis Factor inhibition on the risk and age at onset of Parkinson’s disease: A Mendelian randomization study

X. Kang, A. Ploner, N. Pedersen, J. Ludvigsson, S. Bandres-Ciga, A. Noyce, K. Wirdefeldt, D. Williams (Stockholm, Sweden)

Predictors of transfer to facility or nursing home after discharge of inpatients with Parkinson’s disease: A Japanese single center retrospective study

Y. Higashi, M. Tabata (Himeji, Japan)

Quantitative method for designing appropriate longitudinal follow-up frequency with application to Parkinson’s disease cognition research

L. Suttner, S. Xie (Philadelphia, PA, USA)

Short- and Long-term Healthcare Resource Utilization in Parkinson’s Disease – 20 years of Follow Up in a Population-based Cohort

Y. Barer, N. Gavrielov, I. Goldshtein, M. Martinec, I. Korolev, P. Coloma (Tel Aviv, Israel)

Study on the clinical features of Parkinson’s disease with probable rapid eye movement sleep behavior disorder

J. Liu, Y. Xiang, C. Wan, X. Yan, B. Tang, J. Guo (Changsha, Hunan, China)

Sulpiride-induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients: A Nationwide Population-Based Study

C.Y Wei, M.C Lin, W.M Kung (Changhua County, Taiwan)